Hasil Pencarian - Hessa Al Muqati

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study

    Superinfection rate among the patients treated with carbapenem versus piperacillin/tazobactam: Retrospective observational study oleh Hessa Al Muqati, Abdulrahman Al Turaiki, Fahad Al Dhahri, Huda Al Enazi, Abdullah Althemery

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Population pharmacokinetics of vancomycin in very low birth weight neonates

    Population pharmacokinetics of vancomycin in very low birth weight neonates oleh Abdullah Alsultan, Manea Fares Al Munjem, Khulood Mohammed Atiq, Zekra Kamel Aljehani, Hessa Al Muqati, Abdullah Almohaizeie, Dalia Ahmed Ballal, Tahani Makki Refaei, Majed Al Jeraisy, Majed Al Jeraisy, Majed Al Jeraisy, Abdulmohsen Assiri, Manal Abouelkheir

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study

    The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study oleh Ghazwa B. Korayem, Ohoud Aljuhani, Ali F. Altebainawi, Abdulrahman I. Al Shaya, Lina I. Alnajjar, Abdulrahman Alissa, Mohammed Aldhaeefi, Raed Kensara, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Omar Alhuthaili, Ramesh Vishwakarma, Namareq Aldardeer, Khalid Eljaaly, Aisha Alharbi, Shmeylan Al Harbi, Abdulmalik Al Katheri, Abdulkareem M. Al Bekairy, Ahmed Aljedai, Khalid Al Sulaiman

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study

    The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study oleh Khalid Al Sulaiman, Khalid Al Sulaiman, Khalid Al Sulaiman, Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Shmeylan Al Harbi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Abdulrahman Al Shaya, Abdulrahman Al Shaya, Hisham A. Badreldin, Hisham A. Badreldin, Hisham A. Badreldin, Raed Kensara, Raed Kensara, Abdullah F. Alharthi, Abdullah F. Alharthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Alawi S. Alsaeedi, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Ghassan Al Ghamdi, Ghassan Al Ghamdi, Hadeel Alkofide, Hasan M. Al-Dorzi, Hasan M. Al-Dorzi, Hasan M. Al-Dorzi

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: